tiprankstipranks
Orphazyme (ORPH)
NASDAQ:ORPH
US Market

Orphazyme (ORPH) Stock Investors

0 Followers
Based on 577,958 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold ORPH
On average, investors allocate 0.48% of their portfolios to ORPH
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding ORPH

14.3%
Last 7
Days
1.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding ORPH, out of 577,958 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

ORPH Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.27%
$0.91
Opened
0.16%
$2.21
Closed
0.00%
$2.32
Increased
0.10%
$2.66
Based on the activity of 46,776 investors who made their portfolios public
The table shows changes in ORPH in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

ORPH Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Camber Energy
12.39%
+0.42%
+17.32%
256.28M
Utilities
Marin Software
3.53%
+2.88%
+2.96%
46.30M
Technology
Synthetic Biologics
1.72%
+0.32%
+8.51%
45.20M
Healthcare
Aptose Biosciences
3.54%
+1.57%
+7.52%
125.43M
Healthcare
Meta Materials
6.10%
+0.05%
-3.88%
475.64M
Technology
Clover Health Investments
7.37%
+0.72%
+8.15%
1.68B
Financial
Inovio Pharmaceuticals
3.49%
+5.99%
+11.43%
796.18M
Healthcare
Gevo
7.03%
+1.42%
+7.23%
945.31M
Basic Materials
ContextLogic
6.04%
-0.27%
-1.42%
1.48B
Consumer Goods
Workhorse Group
3.95%
+1.32%
+1.28%
758.38M
Industrial Goods
Based on the activity of 577,958 active portfolios
Open your Smart Portfolio

ORPH Investor Analysis

ORPH investors under 35

Under 35

0.3%
Last 30 days
Holdings Change
12.5%
of ORPH holders
are under 35
Average Segment Performance
Average P/E Ratio-
Beta1.06
Dividend Yield1.39%
ORPH investors between 35–55

Between 35–55

14.2%
Last 30 days
Holdings Change
75.0%
of ORPH holders
are between 35–55
Average Segment Performance
Average P/E Ratio-
Beta1.16
Dividend Yield1.46%
ORPH investors over 55

Over 55

100.0%
Last 30 days
Holdings Change
12.5%
of ORPH holders
are over 55
Average Segment Performance
Average P/E Ratio-
Beta1.04
Dividend Yield1.88%
Overview of age group and performance of ORPH stock investors
See who invests in ORPH according to age group and performance.

FAQ

How many retail Investors hold ORPH?
<0.1% of TipRanks' retail investors hold ORPH in their portfolios.
    What is ORPH Investor Sentiment?
    ORPH’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of ORPH in the last 7 days?
      ▼ 14.3% of TipRanks' retail investors changed their holding of ORPH in the last 7 days.
        What percentage of retail investors changed their holding of ORPH in the last 30 days?
        ▲ 1.0% of TipRanks' retail investors changed their holding of ORPH in the last 30 days.
          What is the average age of retail investors who hold ORPH?
          The average age of ORPH Holders is between 35–55.
            What other stocks have ORPH investors also bought?
            ORPH Investors also bought CEI, MRIN, SYN, APTO, MMAT, CLOV, INO, GEVO, WISH, WKHS.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              PRAXPraxis Precision Medicines
              STTKShattuck Labs
              AZYOAziyo Biologics
              SPRBSpruce Biosciences
              LNSRLENSAR
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis